Table 2.
Variable | Point Estimate | 95% Wald Confidence Limits | P-Value | |
---|---|---|---|---|
Model 1 | ||||
BDI Score - Continuous | 1.14 | 1.05 | 1.24 | 0.002 |
Model 2 | ||||
BDI1 Score - Continuous | 1.15 | 1.05 | 1.25 | 0.002 |
Use of Beta-Blockers | 0.51 | 0.15 | 1.71 | 0.28 |
Diabetes | 0.80 | 0.28 | 2.31 | 0.68 |
Age | 1.04 | 0.98 | 1.10 | 0.18 |
Use of Statins | 0.77 | 0.13 | 4.45 | 0.70 |
Hypertension | 0.44 | 0.12 | 1.67 | 0.77 |
Model 3 | ||||
BDI1 Score ≥ 10 | 3.55 | 1.42 | 8.87 | 0.007 |
Model 4 | ||||
BDI1 Score ≥ 10 | 3.89 | 1.47 | 10.31 | 0.007 |
Use of Beta-Blockers | 0.65 | 0.20 | 2.07 | 0.46 |
Diabetes | 0.86 | 0.30 | 2.45 | 0.77 |
Age | 1.04 | 0.98 | 1.09 | 0.21 |
Use of Statins | 0.79 | 0.14 | 4.48 | 0.79 |
Hypertension | 3.87 | 0.67 | 22.23 | 0.13 |
ET-1 = endothelin-1
BDI = Beck Depression Inventory